Luke Nathaniel Walker, SVP, Clinical Development at Cascadian Therapeutics, holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP), holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC).

See the Hottest Stocks Based on Insider Trading >

Luke Nathaniel Walker
Cascadian Therapeutics (CASC)
SVP, Clinical Development

Not Ranked

Luke Nathaniel Walker has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Luke Nathaniel Walker does not currently own shares as a corporate insider.

A breakdown of Luke Nathaniel Walker's holdings

See the Top Stocks by Insiders

Insider Roles

Luke Nathaniel Walker does not currently hold a role as a corporate insider.

Roles that Luke Nathaniel Walker holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available

The most profitable trade made by Luke Nathaniel Walker

See the Latest Stocks Traded by Insiders

Luke Nathaniel Walker's Trading History

CASC

Cascadian Therapeutics

Mar 13, 2018

―

Uninformative Sell

―

$0.00

HARP

Harpoon Therapeutics

Mar 11, 2024

―

Uninformative Sell

―

$0.00

List of latest transactions for each holding click on a transaction to see Luke Nathaniel Walker's performance on stock

See All Insider Trading from Today

Luke Nathaniel Walker insider profile FAQ

What is the percentage of profitable transactions made by Luke Nathaniel Walker?

The percentage of profitable transactions made by Luke Nathaniel Walker is ―.

What is the average return per transaction made by Luke Nathaniel Walker?

The average return per transaction made by Luke Nathaniel Walker is ―.

What stocks does Luke Nathaniel Walker hold?

Luke Nathaniel Walker holds: CASC, HARP stocks.

What was Luke Nathaniel Walker’s latest transaction?

Luke Nathaniel Walker latest transaction was an Uninformative Sell of ―.

What was Luke Nathaniel Walker's most profitable transaction?

Luke Nathaniel Walker’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.

What is Luke Nathaniel Walker's role in Cascadian Therapeutics?

Luke Nathaniel Walker's role in Cascadian Therapeutics is SVP, Clinical Development.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Luke Nathaniel Walker Insider Profile

Luke Nathaniel Walker Cascadian Therapeutics (CASC)SVP, Clinical Development